BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Announced Today the Stock is Halted
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
BioMarin Pharma (BMRN) will resume trading at 7:10am ET
November 25, 2015 6:53 AM ESTBioMarin Pharma (NASDAQ: BMRN) will resume trading at 7:10am EST.
... MoreBioMarin Pharma (BMRN) Affirms Trading Halt Ahead of FDA Committee Review of Kyndrisa NDA
November 24, 2015 7:08 AM ESTBioMarin Pharma (NASDAQ: BMRN) announced today that NASDAQ has halted trading of the companys stock. The Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) of the U.S. Food and Drug Administration (FDA) is meeting today to review BioMarins New Drug Application... More
